| JYHB0900405 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2009-06-02 | 韩林制药株式会社 | Hanlim Pharmaceutical Co Ltd | Certificate Issued | 2009-12-22 | view |
| JXHL0600128 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs(3.1) | Import Drug Application | 2006-04-30 | 韩林制药株式会社 | Hanlim Pharmaceutical Co Ltd | Certificate Issued | 2009-02-18 | view |
| JXHL0800037 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs(3.1) | Import Drug Application | 2008-01-29 | 韩国联合制药株式会社 | Korea United Pharm Inc | Certificate Issued | 2010-04-15 | view |
| JYHB1600407 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2016-04-06 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-03-07 | view |
| JYHB1400858 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2014-07-01 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-01-04 | view |
| JYHB1500951 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2015-07-17 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2016-07-25 | view |
| JYHB1400857 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2014-07-01 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-01-04 | view |
| JYHZ1700348 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | License Renew | 2017-11-20 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-10-11 | view |
| JYHB1100832 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2011-10-10 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2012-05-14 | view |
| JYHB1500950 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2015-07-17 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2016-07-25 | view |
| JYHZ1200270 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | License Renew | 2013-03-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2013-12-17 | view |
| JYHZ1700347 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | License Renew | 2017-11-20 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2018-10-11 | view |
| JYHZ1200269 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | License Renew | 2013-03-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2013-12-17 | view |
| JYHB1600406 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2016-04-06 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2017-03-07 | view |
| JYHB1100831 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2011-10-10 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd | Certificate Issued | 2012-05-14 | view |
| CYHB2100218 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2021-02-05 | 辉瑞制药（无锡）有限公司 | Pfizer Pharmaceutical (Wuxi) Co Ltd | In Review | 2021-02-04 | view |
| CYHB1101559 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2011-05-27 | 辉瑞制药（无锡）有限公司 | Pfizer Pharmaceutical (Wuxi) Co Ltd | Certificate Issued | 2011-10-13 | view |
| CYHB2100217 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2021-02-05 | 辉瑞制药（无锡）有限公司 | Pfizer Pharmaceutical (Wuxi) Co Ltd | In Review | 2021-02-04 | view |
| CYHB1101560 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs | Supplementary Application | 2011-05-27 | 辉瑞制药（无锡）有限公司 | Pfizer Pharmaceutical (Wuxi) Co Ltd | Certificate Issued | 2011-10-13 | view |
| CYHS1401459 | 注射用盐酸伊达比星 | idarubicin hydrochloride | Lyophilized | Chemical Drugs(6) | Generic Drug | 2015-07-10 | 苏州二叶制药有限公司 | Suzhou Erye Pharmaceutical Co Ltd | Certificate Issued | 2021-04-01 | view |
